Page last updated: 2024-08-18

chalcone and Pulmonary Hypertension

chalcone has been researched along with Pulmonary Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, X; Long, Y; Zhang, X; Zhang, Y; Zhou, Z1
Bai, Y; Cao, F; Dong, P; He, F; Hou, C; Li, L; Li, S; Song, Y; Sun, S; Zhu, D1

Other Studies

2 other study(ies) available for chalcone and Pulmonary Hypertension

ArticleYear
Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats.
    The Journal of international medical research, 2016, Volume: 44, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Chalcone; Deoxyguanosine; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation; Male; Malondialdehyde; Monocrotaline; Oxidative Stress; Quinones; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Vascular Remodeling

2016
Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    Journal of ethnopharmacology, 2016, Jun-20, Volume: 186

    Topics: Animals; Carthamus tinctorius; Cell Survival; Cells, Cultured; Chalcone; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Myocytes, Smooth Muscle; Phytotherapy; Pulmonary Artery; Quinones; Rats, Wistar; Vascular Remodeling

2016
chemdatabank.com